References
- Arvidsson L.-E., Hacksell U., Johansson A. M., Nilsson J. L. G., Lindberg P., Sanchez D., Wikström H., Svensson K., Hjorth S., Carlsson A. 8-Hydroxy-2-(alky-lamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists. Joiurnal of Medical Chemistrt 1984; 27: 45–51
- Arvidsson L.-E., Hacksell U., Nilsson J. L. G., Hjorth S., Carlsson A., Lindberg P., Sanchez D., Wikström H. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. Journal of Medicine Chemistry 1981; 24: 921–923
- Björk L., Höök B. B., Nelson D. L., Anden N-E., Hacksell U. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain. Journal of Medical Chemistry 1989; 32: 779–783
- Caldwell J. Comparative aspects of detoxication in mammals. Enzymatic Basis of Detoxication, W. B. Jakoby. Academic, New York 1980; vol. I: 85–114
- Gerding T. K., Drenth B. F. H., Roosenstein H. J., de Zeeuw R. A., Tepper P. G., Horn A. S. The metabolic fate of the dopamine agonist 2-(N-propyl-2-N-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration. I. Disposition and metabolic profiling. Xenobiotica 1990a; 20: 515–525
- Gerding T. K., Drenth B. F. H., de Zeeuw R. A., Tepper P. G., Horn A. S. The metabolic fate of the dopamine agonist 2-(N-propyl-2-N-thienylethylamino)-5-hydroxy-tetralin in rats after intravenous and oral administration. II Isolation and identification of metabolites. Xenobiotica 1990b; 20: 525–536
- Koble D. L., Koons J. C., Fischer L. J. Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat. Drug Metabolism and Disposition 1985; 13: 305–311
- Lindeke B., Cho A. K. N-dealkylation and deamination. Metabolic Basis of Detoxication, W. B. Jakoby, J. R. Bend, J. Caldwell. Academic, New York 1982; 105–126
- Mason J. P., Dring L. G., Caldwell J. The metabolism of 8-OHDPAT in rats. British Journal of Pharmacology 1992; 106: 58P
- Middlemiss D. N., Fozard J. R. 8-Hydroxy-2-(di-n-propylamino)tetralin discriminates between subtypes of the 5-HT1 recognition site. European Journal of Pharmacology 1983; 90: 151–153
- Mulder G. J. Conjugation of phenols. Metabolic Basis of Detoxication, W. B. Jakoby, J. R. Bend, J. Caldwell. Academic, New York 1982; 247–269
- Mulder G. J. Competition between conjugations for the same substrate. Conjugation Reactions in Drug Metabolism, G. J. Mulder. Taylor & Francis, London 1990; 41–50
- Perry K. W., Fuller R. Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromtography with electrochemical detection. Biochemical Pharmacology 1989; 38: 3169–3173
- Sonesson C., Boije M., Svensson K., Ekman A., Carlsson A., Romero A. G., Martin I. J., Duncan J. N., King L. J., Wikström H. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[(trifluoromethyl)sulphonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo. Journal of Medical Chemistry 1993; 36: 3409–3416
- Swart P. J., Jansman F. G. A., Drenth B. F. H., de Zeeuw R. A., Dijkstra D., Horn A. S. Impact of structural differences on the in vitro glucuronidation kinetics of potentially dopaminergic hydroxy-2-aminotetralins and naphthoxazines using rat and human liver microsomes. Pharmacology and Toxicology 1991; 68: 215–219
- Wikström H., Elebring T., Hallnemo G., Andersson B., Svensson K., Carlsson A., Rollema H. Occurrence and pharmacological sigificance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin. Journal of Medical Chemistry 1988; 31: 1080–1084